Patents by Inventor Shmuel Sternberg

Shmuel Sternberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6899834
    Abstract: Membranes and methods for making membranes are disclosed. The membranes include a polymeric matrix and a particulate material immobilized within the matrix. The membranes may find particular application in methods and apparatus for removing organic compounds from a biological fluid as part of a pathogen inactivation treatment.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: May 31, 2005
    Assignee: Baxter International Inc.
    Inventors: Daniel R. Boggs, Shmuel Sternberg, Robin G. Pauley, Donna L. McLarty
  • Publication number: 20050037083
    Abstract: The present invention provides a method for preparing submicron-sized particles. The method includes the steps of: (1) providing a multiphase system having an organic phase and an aqueous phase, the organic phase having a pharmaceutically effective compound therein; and (2) sonicating the system to evaporate a portion of the organic phase to cause precipitation of the compound in the aqueous phase and having an average effective particle size of less than about 2 m.
    Type: Application
    Filed: May 10, 2002
    Publication date: February 17, 2005
    Inventors: Sean Brynjelsen, Shmuel Sternberg, Andy Dunham
  • Patent number: 6824688
    Abstract: A filter for removing leukocytes from blood comprises a filter media enclosed in a housing. The filter media includes a main filter region comprising a porous membrane structure extending between first and second skin surfaces. The porous membrane structure is formed by intersecting cells having a range of diameters. The cells adjacent to the first skin surface have diameters generally smaller than the diameters of the cells adjacent to the second skin surface. The first skin surface includes an open area defined by pores, which are formed by the intersection of cells with the first skin surface. The majority of the open area is defined by pores having a diameter of between about 12 &mgr;m and 28 &mgr;m.
    Type: Grant
    Filed: June 26, 2003
    Date of Patent: November 30, 2004
    Assignee: Baxter International Inc.
    Inventors: Julian P. Breillatt, Jr., Shmuel Sternberg
  • Publication number: 20040043224
    Abstract: Enhanced hydrophobic membranes and methods of making such membranes are disclosed. The membranes are made of a polymer, such as polyvinylidene difluoride coated with a fluorochemical acrylate polymer to enhance hydrophobicity. Membranes of the type described above are made without cross-linking, grafting or in situ polymerization.
    Type: Application
    Filed: August 30, 2002
    Publication date: March 4, 2004
    Inventor: Shmuel Sternberg
  • Publication number: 20030234226
    Abstract: A filter for removing leukocytes from blood comprises a filter media enclosed in a housing. The filter media includes a main filter region comprising a porous membrane structure extending between first and second skin surfaces. The porous membrane structure is formed by intersecting cells having a range of diameters. The cells adjacent to the first skin surface have diameters generally smaller than the diameters of the cells adjacent to the second skin surface. The first skin surface includes an open area defined by pores, which are formed by the intersection of cells with the first skin surface. The majority of the open area is defined by pores having a diameter of between about 12 &mgr;m and 28 &mgr;m.
    Type: Application
    Filed: June 26, 2003
    Publication date: December 25, 2003
    Applicant: Baxter International Inc.
    Inventors: Julian P. Breillatt, Shmuel Sternberg
  • Patent number: 6612447
    Abstract: A filter for removing leukocytes from blood comprises a filter media enclosed in a housing. The filter media includes a main filter region comprising a porous membrane structure extending between first and second skin surfaces. The porous membrane structure is formed by intersecting cells having a range of diameters. The cells adjacent to the first skin surface have diameters generally smaller than the diameters of the cells adjacent to the second skin surface. The first skin surface includes an open area defined by pores, which are formed by the intersection of cells with the first skin surface. The majority of the open area is defined by pores having a diameter of between about 12 &mgr;m and 28 &mgr;m.
    Type: Grant
    Filed: July 24, 2000
    Date of Patent: September 2, 2003
    Assignee: Baxter International Inc.
    Inventors: Julian P. Breillatt, Jr., Shmuel Sternberg
  • Patent number: 6596230
    Abstract: A device and method for inactivating pathogens in therapeutic fluids with sterilizing radiation in a continuous thin fluid flow arrangement that exhibits radiation dose uniformity for fluids having high optical densities. Radiation dose uniformity is achieved in part through a “carrying” mechanism that moves or carries the fluid, thereby eliminating a channel flow velocity profile where flow volumes near the channel walls run the risk of overexposure to the radiation due to very large residence times within the channel. The device comprises a relatively flat belt chamber (22) connected to a fluid flow through an inlet (24) and an outlet (26) on the belt chamber (22). The belt chamber (22) has a top surface (28) and a bottom surface (30). A radiation permeable plate (32) is disposed adjacent the top surface (28) of the belt chamber (22) and is in contact with the belt chamber (22). A radiation source (42) is provided adjacent to the plate (32) adjacent to a side opposite the belt chamber (22).
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: July 22, 2003
    Assignee: Baxter International Inc.
    Inventors: Lecon Woo, Daniel R. Boggs, Shmuel Sternberg, Craig Sandford, Atul Khare, Julian Breillatt
  • Publication number: 20030113932
    Abstract: A membrane capable of sensing gaseous phase ammonia is provided. The membrane includes a hydrophobic membrane layer that has a microporous structure and a pH sensitive dye embedded within the microporous structure such that the membrane is capable of calorimetrically sensing a change in ammonia with a high degree of sensitivity and responsiveness as applied to, for example, a change in ammonia dissolved in a dialysis solution during dialysis therapy.
    Type: Application
    Filed: December 14, 2001
    Publication date: June 19, 2003
    Inventors: Shmuel Sternberg, Daniel Boggs, Rosa Yeh, Li Pan
  • Patent number: 6576201
    Abstract: A device and method for inactivating pathogens in therapeutic fluids with sterilizing radiation in a continuous flow arrangement while exhibiting radiation dose uniformity and narrow residence time distribution of the fluid within the device. The device (10) comprises a radiation permeable cylindrical tube (12) having a concentric cylindrical rotor (14) disposed therein, thereby providing a thin gap (16) therebetween. A top plate (18) having a fluid outlet (26) and a bottom plate (20) having a fluid inlet (24) seal the cylindrical tube (12). The inlet (24) and outlet (26) are both in fluid communication with the thin gap (16). A rotor shaft (36) is disposed axially through the cylindrical rotor (14) and is connected to a motor (30). A pump provides fluid flow through the device (10). A radiation source provides sterilizing radiation to the fluid through the cylindrical tube (12).
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: June 10, 2003
    Assignee: Baxter International Inc.
    Inventors: Lecon Woo, Daniel R. Boggs, Shmuel Sternberg, Craig Sandford, Atul Khare, Julian Breillatt
  • Patent number: 6497821
    Abstract: A method and apparatus for filtering suspensions of medical and biological fluids, one aspect of which is separating a suspension comprising at least two types of particles which are differently sized or shaped and in which the first type of particle may be deformable at a relatively lower force and/or faster rate than the second type of particle. A filter member is provided having substantially precisely dimensioned pore sizes, with the pores being dimensioned to allow passage of the first type of suspended particle without distortion or only minimal distortion and passage of the second type of particle only with substantial distortion.
    Type: Grant
    Filed: May 17, 1999
    Date of Patent: December 24, 2002
    Assignee: Baxter International Inc.
    Inventors: David Bellamy, Jr., Paul R. Prince, Michael O. Pekkarinen, Shmuel Sternberg
  • Patent number: 6491819
    Abstract: An apparatus is disclosed for separating a suspension comprising at least two types of particles which are differently sized or shaped and in which the first type of particle may be deformable at a relatively lower force or faster rate than the second type of particle. A housing is provided having a generally cylindrical inner surface in which is mounted a rotor having a generally cylindrical outer surface. The outer surface of the rotor is spaced from the inner surface of the housing to define a suspension processing gap. A filter membrane is provided on the surface of the rotor or the housing that has pores with substantially precisely dimensioned shapes and sizes to correspond substantially to the shape of the first type of particle, thus allowing passage of the first type of particle and blocking passage of the second type of particle. A suspension is directed into the processing gap for either a selected residence time in contact with the filter membrane and/or at a selected force.
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: December 10, 2002
    Assignee: Baxter International Inc.
    Inventors: Paul R. Prince, Michael O. Pekkarinen, David Bellamy, Jr., Shmuel Sternberg
  • Publication number: 20020066699
    Abstract: Membranes and methods for making membranes are disclosed. The membranes include a polymeric matrix and a particulate material immobilized within the matrix. The membranes may find particular application in methods and apparatus for removing organic compounds from a biological fluid as part of a pathogen inactivation treatment.
    Type: Application
    Filed: November 30, 2001
    Publication date: June 6, 2002
    Inventors: Daniel R. Boggs, Shmuel Sternberg, Robin G. Pauley, Donna L. McLarty
  • Publication number: 20020033367
    Abstract: A method and apparatus for filtering suspensions of medical and biological fluids, one aspect of which is separating a suspension comprising at least two types of particles which are differently sized or shaped and in which the first type of particle may be deformable at a relatively lower force and/or faster rate than the second type of particle. A filter member is provided having substantially precisely dimensioned pore sizes, with the pores being dimensioned to allow passage of the first type of suspended particle without distortion or only minimal distortion and passage of the second type of particle only with substantial distortion.
    Type: Application
    Filed: September 18, 2001
    Publication date: March 21, 2002
    Applicant: Baxter International Inc.
    Inventors: Paul R. Prince, Michael O. Pekkarinen, David Bellamy, Shmuel Sternberg
  • Patent number: 6099734
    Abstract: Membranes and methods for making membranes are disclosed. The membranes include a polymeric matrix and a particulate material immobilized within the matrix. The membranes may find particular application in methods and apparatus for removing organic compounds from a biological fluid as part of a pathogen inactivation treatment.
    Type: Grant
    Filed: July 8, 1998
    Date of Patent: August 8, 2000
    Assignee: Baxter International Inc.
    Inventors: Daniel R. Boggs, Derek J. Hei, Shmuel Sternberg, Robin G. Pauley, Donna L. McLarty
  • Patent number: 6060640
    Abstract: A permeable structure forms a chamber to hold living cells. The structure includes a first permeable region surrounding at least a portion of the chamber having a conformation that, when implanted in host tissue, substantially blocks penetration of host cells into the chamber while permitting solute transport. The structure also includes a second permeable region overlying the first permeable region having a conformation that, when implanted in host tissue, forms a permeable interface with host tissue that permits solute transport. A third permeable region is located between the first and second permeable regions. The third region comprises a solution of polymer material formed in place between the first and second permeable regions. The third permeable region bonds the first and second permeable regions together. The third permeable region also has a conformation that, when implanted in host tissue, permits solute transport between the first and second permeable regions.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: May 9, 2000
    Assignee: Baxter International Inc.
    Inventors: Robin G. Pauley, Donna L. McLarty, Atul R. Khare, Shmuel Sternberg, Daniel R. Boggs, Steven Neuenfeldt, Mark Jones, James H. Brauker, Laura A. Martinson
  • Patent number: 6032807
    Abstract: A method correlates average fiber diameter with performance for a complex filtration media comprising a matrix of fibers having a fibrillated component with a diameter so small (e.g., less than 0.01 microns), that cannot be physically measured with accuracy. The method manufactures a selected matrix, derives the number average diameter of the fibers according to prescribed steps, some of which do not require actual physical measurements, and observes a performance characteristic. The method repeats the foregoing steps for different matrixes, yielding different number average diameters. The method expresses change in the selected performance characteristic as a function of change in number average diameter of the matrices.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: March 7, 2000
    Assignee: Baxter International Inc.
    Inventors: Shmuel Sternberg, Daniel R. Lynn
  • Patent number: 5807406
    Abstract: Polymer membrane structures are microfabricated from polyimide film by lithography or etching. The microfabricated structures have systematically varied dimensions and geometries conducive to implanting in host tissue and the promotion, when implanted, of new vascular structures.
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: September 15, 1998
    Assignee: Baxter International Inc.
    Inventors: James H. Brauker, Laura A. Martinson, Shmuel Sternberg, David Bellamy
  • Patent number: 5653756
    Abstract: Improved Implant assemblies and methodologies provide immuno-protection for implanted allografts, xenografts, and isografts. The assemblies and methodologies establish an improved chamber for holding the implanted cells. The chambers include first and second wall elements and an intermediate sealing element. The first and second wall elements overlie an open area in the sealing member to form a chamber for holding cells for implantation. A sealed region is created between the wall elements and the sealing element body to close the chamber. In one arrangement, the sealed region is created by means of a sonic weld made while the implanted cells are present in the chamber. In another arrangement, the sealed region is created by means of applying an external force to compress the peripheral edges of the wall elements and the sealing element together while the implanted cells are present in the chamber.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: August 5, 1997
    Assignee: Baxter International Inc.
    Inventors: Robert A. Clarke, Robin G. Pauley, Ronald S. Hill, James H. Brauker, Shmuel Sternberg, Daniel R. Boggs
  • Patent number: 5344454
    Abstract: Improved Implant assemblies and methodologies provide immuno-protection for implanted allografts, xenografts, and isografts. The assemblies and methodologies establish an improved chamber for holding the implanted cells. The chambers include first and second wall elements and an intermediate sealing element. The first and second wall elements overlie an open area in the sealing member to form a chamber for holding cells for implantation. A sealed region is created between the wall elements and the sealing element body to close the chamber. In one arrangement, the sealed region is created by means of a sonic weld made while the implanted cells are present in the chamber. In another arrangement, the sealed region is created by means of applying an external force to compress the peripheral edges of the wall elements and the sealing element together while the implanted cells are present in the chamber.
    Type: Grant
    Filed: April 1, 1992
    Date of Patent: September 6, 1994
    Assignee: Baxter International Inc.
    Inventors: Robert A Clarke, Robin G. Pauley, Ronald S. Hill, James H. Brauker, Shmuel Sternberg, Daniel R. Boggs
  • Patent number: 4935142
    Abstract: Provided, is a membrane unit which can sealably accommodate a variable plurality of stacked planar membrane elements.
    Type: Grant
    Filed: June 23, 1989
    Date of Patent: June 19, 1990
    Assignee: Memtek Corporation
    Inventor: Shmuel Sternberg